Liver function may change how cough drug works
NCT ID NCT06222892
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how camlipixant, an experimental drug for chronic cough, behaves in people with liver problems compared to healthy volunteers. 32 adults aged 18-75 took part to see if liver impairment changes drug levels or safety. The goal is to help doctors decide the right dose for patients with liver issues.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COUGH are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
GSK Investigational Site
Miami, Florida, 33136, United States
-
GSK Investigational Site
Orlando, Florida, 32809, United States
-
GSK Investigational Site
San Antonio, Texas, 78215, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple breathing test unlock the secrets of chronic cough?
- Could a new dissolving tablet quiet coughs? safety trial begins
- Liver health and drug processing: a closer look at casdatifan
- Liver function may change how belapectin works in the body
- New pill aims to silence chronic cough that Won't quit
- Asthma in children may hide behind unusual symptoms, study reveals